Nolfe G - Search Results

1

Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort.

Manco M, Nolfe G, Pataky Z, Monti L, Porcellati F, Gabriel R, Mitrakou A, Mingrone G. Manco M, et al. Among authors: nolfe g. Metabolism. 2017 May;70:42-50. doi: 10.1016/j.metabol.2017.02.007. Epub 2017 Feb 14. Metabolism. 2017. PMID: 28403944

2

Menopause, insulin resistance, and risk factors for cardiovascular disease.

Manco M, Nolfe G, Calvani M, Natali A, Nolan J, Ferrannini E, Mingrone G; European Group for the Study of Insulin Resistance. Manco M, et al. Among authors: nolfe g. Menopause. 2006 Sep-Oct;13(5):809-17. doi: 10.1097/01.gme.0000233492.38638.74. Menopause. 2006. PMID: 16900080

3

Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth.

Nolfe G, Spreghini MR, Sforza RW, Morino G, Manco M. Nolfe G, et al. Eur J Endocrinol. 2012 Jan;166(1):107-14. doi: 10.1530/EJE-11-0827. Epub 2011 Oct 18. Eur J Endocrinol. 2012. PMID: 22009494

4

Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.

Mingrone G, Manco M, Iaconelli A, Gniuli D, Bracaglia R, Leccesi L, Calvani M, Nolfe G, Basu S, Berria R. Mingrone G, et al. Among authors: nolfe g. Obesity (Silver Spring). 2008 Aug;16(8):1831-7. doi: 10.1038/oby.2008.297. Epub 2008 Jun 5. Obesity (Silver Spring). 2008. PMID: 18535540 Free article.

5

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion.

Mingrone G, Nolfe G, Gissey GC, Iaconelli A, Leccesi L, Guidone C, Nanni G, Holst JJ. Mingrone G, et al. Among authors: nolfe g. Diabetologia. 2009 May;52(5):873-81. doi: 10.1007/s00125-009-1288-9. Epub 2009 Feb 20. Diabetologia. 2009. PMID: 19229515

6

Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance.

Moreno-Navarrete JM, Manco M, Ibáñez J, García-Fuentes E, Ortega F, Gorostiaga E, Vendrell J, Izquierdo M, Martínez C, Nolfe G, Ricart W, Mingrone G, Tinahones F, Fernández-Real JM. Moreno-Navarrete JM, et al. Among authors: nolfe g. Int J Obes (Lond). 2010 Feb;34(2):240-9. doi: 10.1038/ijo.2009.242. Epub 2009 Dec 1. Int J Obes (Lond). 2010. PMID: 19949414

7

Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.

Dal Lago A, De Martini D, Flore R, Gaetani E, Gasbarrini A, Gerardino L, Pola R, Santoliquido A, Serricchio M, Tondi P, Nolfe G. Dal Lago A, et al. Among authors: nolfe g. Drugs Exp Clin Res. 1999;25(1):29-36. Drugs Exp Clin Res. 1999. PMID: 10337502 Clinical Trial.

8

Rheological activity of propionyl L-carnitine.

Pola P, Flore R, Tondi P, Nolfe G. Pola P, et al. Among authors: nolfe g. Drugs Exp Clin Res. 1991;17(3):191-6. Drugs Exp Clin Res. 1991. PMID: 1914846

9

Quality of life after stroke in a rehabilitation setting.

Giaquinto S, Giachetti I, Spiridigliozzi C, Nolfe G. Giaquinto S, et al. Among authors: nolfe g. Clin Exp Hypertens. 2010;32(7):426-30. doi: 10.3109/10641961003667963. Epub 2010 Sep 27. Clin Exp Hypertens. 2010. PMID: 20874223

10

Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.

Coto V, D'Alessandro L, Grattarola G, Imparato L, Lingetti M, Mancini M, Nolfe G, Rengo F. Coto V, et al. Among authors: nolfe g. Drugs Exp Clin Res. 1992;18(1):29-36. Drugs Exp Clin Res. 1992. PMID: 1600865 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page